Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy

J Iversen, GJ Dore, M Starr, B Catlett… - International Journal of …, 2020 - Elsevier
Background Monitoring the hepatitis C virus (HCV) cascade of care (CoC) among people
who inject drugs (PWID) is an essential component of the response to World Health …

[HTML][HTML] HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

K Suzuki, A Levert, J Yeung, M Starr, J Cameron… - Aids, 2021 - journals.lww.com
Objective: Some HIV+ patients, virally suppressed on ART, show occasional ‘blips’ of
detectable HIV-1 plasma RNA. We used a new highly sensitive assay of cell-associated HIV-1 …

High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells

…, ML Faulks, H Law, T Danwilai, M Starr… - Frontiers in …, 2022 - frontiersin.org
Background Long-term immunity to SARS-CoV-2 infection, including neutralizing antibodies
and T cell-mediated immunity, is required in a very large majority of the population in order …

Hepatitis C treatment uptake following dried blood spot testing for hepatitis C RNA in New South Wales, Australia: the NSW DBS Pilot study

…, C McGrath, P Read, M Starr… - Open forum …, 2023 - academic.oup.com
Background Dried blood spot (DBS) testing for hepatitis C virus (HCV) RNA provides a
sampling option that avoids venepuncture and can be carried out in a nonclinical setting. Large-…

Clinical signs of trachoma and laboratory evidence of ocular Chlamydia trachomatis infection in a remote Queensland community: a serial cross‐sectional study

…, G Brian, L Ketchup, K Kingston, M Starr… - Medical Journal of …, 2022 - Wiley Online Library
Objectives To compare the findings of standard clinical assessments and of complementary
clinical and laboratory methods for determining whether community‐wide treatment for …

[HTML][HTML] Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection

B Catlett, M Starr, DA Machalek, T Danwilai… - Journal of Clinical …, 2022 - Elsevier
Background Dried blood spot (DBS) specimens are a useful serosurveillance tool particularly
in hard-to-reach populations but their application for detecting SARS-CoV-2 infection is …

Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots

B Catlett, A Carrera, M Starr, TL Applegate… - Journal of Clinical …, 2019 - Elsevier
Background The availability of effective direct-acting antiviral therapy for hepatitis C virus (HCV)
has led to a need for simplified diagnostic pathways. Barriers to treatment uptake, …

[PDF][PDF] Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

TN Starr, AJ Greaney, SK Hilton, D Ellis, KHD Crawford… - cell, 2020 - cell.com
The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral
attachment to ACE2 receptor and is a major determinant of host range and a dominant target …

Screening spinouts? How noncompete enforceability affects the creation, growth, and survival of new firms

E Starr, N Balasubramanian… - Management …, 2018 - pubsonline.informs.org
This paper examines how the enforceability of noncompete covenants affects the creation,
growth, and survival of spinouts and other new entrants. The impact of noncompete …

Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

N Carrington, A Conway, J Grebely, M Starr… - BMC Infectious …, 2024 - Springer
Background Dried blood spot (DBS) testing provides an alternative to phlebotomy and
addresses barriers to accessing healthcare experienced by some key populations. Large-scale …